Logo image of BGS

B&G FOODS INC (BGS) Stock Fundamental Analysis

USA - NYSE:BGS - US05508R1068 - Common Stock

4.61 USD
-0.35 (-7.06%)
Last: 11/7/2025, 8:04:00 PM
4.63 USD
+0.02 (+0.43%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BGS. BGS was compared to 87 industry peers in the Food Products industry. BGS may be in some trouble as it scores bad on both profitability and health. BGS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BGS had positive earnings in the past year.
BGS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BGS reported negative net income in multiple years.
Each year in the past 5 years BGS had a positive operating cash flow.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of BGS (-7.62%) is worse than 72.41% of its industry peers.
With a Return On Equity value of -44.65%, BGS is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
BGS has a Return On Invested Capital of 5.46%. This is in the better half of the industry: BGS outperforms 62.07% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BGS is significantly below the industry average of 28.25%.
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROIC 5.46%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a decent Operating Margin value of 9.93%, BGS is doing good in the industry, outperforming 73.56% of the companies in the same industry.
BGS's Operating Margin has declined in the last couple of years.
BGS's Gross Margin of 21.37% is in line compared to the rest of the industry. BGS outperforms 52.87% of its industry peers.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 9.93%
PM (TTM) N/A
GM 21.37%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BGS is destroying value.
The number of shares outstanding for BGS has been increased compared to 1 year ago.
BGS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BGS is higher compared to a year ago.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BGS has an Altman-Z score of 1.38. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
BGS has a worse Altman-Z score (1.38) than 62.07% of its industry peers.
BGS has a debt to FCF ratio of 15.92. This is a negative value and a sign of low solvency as BGS would need 15.92 years to pay back of all of its debts.
BGS has a Debt to FCF ratio (15.92) which is comparable to the rest of the industry.
BGS has a Debt/Equity ratio of 3.96. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.96, BGS is doing worse than 88.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Altman-Z 1.38
ROIC/WACC0.77
WACC7.09%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

BGS has a Current Ratio of 2.93. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
BGS has a Current ratio of 2.93. This is amongst the best in the industry. BGS outperforms 81.61% of its industry peers.
BGS has a Quick Ratio of 2.93. This is a bad value and indicates that BGS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.89, BGS perfoms like the industry average, outperforming 50.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 0.89
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

BGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.74%.
BGS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.66% yearly.
The Revenue has decreased by -6.30% in the past year.
The Revenue has been growing slightly by 3.08% on average over the past years.
EPS 1Y (TTM)-21.74%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%15.38%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.72%

3.2 Future

The Earnings Per Share is expected to grow by 1.86% on average over the next years.
The Revenue is expected to decrease by -1.92% on average over the next years.
EPS Next Y-28.15%
EPS Next 2Y-14.59%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue Next Year-5.19%
Revenue Next 2Y-3.18%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.54, which indicates a very decent valuation of BGS.
BGS's Price/Earnings ratio is rather cheap when compared to the industry. BGS is cheaper than 88.51% of the companies in the same industry.
BGS is valuated cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.03, which indicates a very decent valuation of BGS.
Based on the Price/Forward Earnings ratio, BGS is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, BGS is valued rather cheaply.
Industry RankSector Rank
PE 8.54
Fwd PE 9.03
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BGS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BGS is cheaper than 60.92% of the companies in the same industry.
95.40% of the companies in the same industry are more expensive than BGS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.95
EV/EBITDA 9.6
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.59%
EPS Next 3Y1.86%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 15.32%, BGS is a good candidate for dividend investing.
BGS's Dividend Yield is rather good when compared to the industry average which is at 5.19. BGS pays more dividend than 97.70% of the companies in the same industry.
BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 15.32%

5.2 History

The dividend of BGS decreases each year by -16.37%.
BGS has paid a dividend for at least 10 years, which is a reliable track record.
BGS has decreased its dividend recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of BGS are negative and hence is the payout ratio. BGS will probably not be able to sustain this dividend level.
DP-26.91%
EPS Next 2Y-14.59%
EPS Next 3Y1.86%
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

B&G FOODS INC

NYSE:BGS (11/7/2025, 8:04:00 PM)

After market: 4.63 +0.02 (+0.43%)

4.61

-0.35 (-7.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners80.57%
Inst Owner Change-0.41%
Ins Owners3.75%
Ins Owner Change6%
Market Cap368.80M
Revenue(TTM)1.93B
Net Income(TTM)-223.89M
Analysts48.33
Price Target4.59 (-0.43%)
Short Float %18.15%
Short Ratio5.66
Dividend
Industry RankSector Rank
Dividend Yield 15.32%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-26.91%
Div Incr Years0
Div Non Decr Years1
Ex-Date09-30 2025-09-30 (0.19)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.51%
Min EPS beat(2)-74.14%
Max EPS beat(2)-32.87%
EPS beat(4)1
Avg EPS beat(4)-35.28%
Min EPS beat(4)-74.14%
Max EPS beat(4)0.96%
EPS beat(8)3
Avg EPS beat(8)-19.64%
EPS beat(12)6
Avg EPS beat(12)-1.04%
EPS beat(16)6
Avg EPS beat(16)-6.9%
Revenue beat(2)0
Avg Revenue beat(2)-5.11%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-3.51%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.33%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.99%
PT rev (1m)0%
PT rev (3m)-16.92%
EPS NQ rev (1m)-2.63%
EPS NQ rev (3m)-18.71%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)-12.29%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-4.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 8.54
Fwd PE 9.03
P/S 0.2
P/FCF 2.95
P/OCF 2.37
P/B 0.74
P/tB N/A
EV/EBITDA 9.6
EPS(TTM)0.54
EY11.71%
EPS(NY)0.51
Fwd EY11.08%
FCF(TTM)1.56
FCFY33.9%
OCF(TTM)1.94
OCFY42.16%
SpS23.28
BVpS6.27
TBVpS-16.48
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.73
Profitability
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.57%
ROICexgc 18.19%
OM 9.93%
PM (TTM) N/A
GM 21.37%
FCFM 6.71%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
ROICexc(3y)5.54%
ROICexc(5y)5.56%
ROICexgc(3y)18%
ROICexgc(5y)19.45%
ROCE(3y)6.91%
ROCE(5y)6.94%
ROICexgc growth 3Y2.98%
ROICexgc growth 5Y-1.12%
ROICexc growth 3Y8.5%
ROICexc growth 5Y3.01%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Debt/EBITDA 8.16
Cap/Depr 52.33%
Cap/Sales 1.63%
Interest Coverage 1.28
Cash Conversion 63.94%
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 0.89
Altman-Z 1.38
F-Score4
WACC7.09%
ROIC/WACC0.77
Cap/Depr(3y)32.37%
Cap/Depr(5y)38.33%
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.74%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%15.38%
EPS Next Y-28.15%
EPS Next 2Y-14.59%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.72%
Revenue Next Year-5.19%
Revenue Next 2Y-3.18%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A
EBIT growth 1Y-45.37%
EBIT growth 3Y-0.88%
EBIT growth 5Y0.92%
EBIT Next Year21.31%
EBIT Next 3Y8.53%
EBIT Next 5YN/A
FCF growth 1Y28.12%
FCF growth 3Y27.08%
FCF growth 5Y90.64%
OCF growth 1Y32.55%
OCF growth 3Y11.71%
OCF growth 5Y23%

B&G FOODS INC / BGS FAQ

What is the fundamental rating for BGS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BGS.


What is the valuation status of B&G FOODS INC (BGS) stock?

ChartMill assigns a valuation rating of 6 / 10 to B&G FOODS INC (BGS). This can be considered as Fairly Valued.


What is the profitability of BGS stock?

B&G FOODS INC (BGS) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for BGS stock?

The Price/Earnings (PE) ratio for B&G FOODS INC (BGS) is 8.54 and the Price/Book (PB) ratio is 0.74.


What is the financial health of B&G FOODS INC (BGS) stock?

The financial health rating of B&G FOODS INC (BGS) is 2 / 10.